ABIN965887

antibody from antibodies-online

Targeting: CHEK2 bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53

Western blot (Recommended by provider)

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Antibody Data

Product number

ABIN965887

Provider

antibodies-online

Product name

anti-Checkpoint Kinase 2 (CHEK2) (AA 481-531) antibody

Antibody type

Monoclonal

Description

Ascitic fluid

Reactivity

Human

Host

Mouse

Epitope

AA 481-531

Isotype

IgG

Antibody clone number

1C12B8

Vial size

0.1 mL

Storage

4°C

References

Submitted references

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.

Cybulski C, Masojc B, Oszutowska D, Jaworowska E, Grodzki T, Waloszczyk P, Serwatowski P, Pankowski J, Huzarski T, Byrski T, Górski B, Jakubowska A, Debniak T, Wokolorczyk D, Gronwald J, Tarnowska C, Serrano-Fernández P, Lubinski J, Narod SA
Carcinogenesis 2008 Apr;29(4):762-5

---

Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures.

Nat R, Nilbratt M, Narkilahti S, Winblad B, Hovatta O, Nordberg A
Glia 2007 Mar;55(4):385-99

---

CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?

Antoni L, Sodha N, Collins I, Garrett MD
Nature reviews. Cancer 2007 Dec;7(12):925-36

---

Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.

Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Le Marchand L, Henderson BE, Altshuler D, Haber DA, Freedman ML
International journal of cancer. Journal international du cancer 2007 Dec 15;121(12):2661-7